| Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver B Costa-Silva, NM Aiello, AJ Ocean, S Singh, H Zhang, BK Thakur, ... Nature cell biology 17 (6), 816-826, 2015 | 2580 | 2015 |
| EMT and dissemination precede pancreatic tumor formation AD Rhim, ET Mirek, NM Aiello, A Maitra, JM Bailey, F McAllister, ... Cell 148 (1), 349-361, 2012 | 2297 | 2012 |
| Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma AD Rhim, PE Oberstein, DH Thomas, ET Mirek, CF Palermo, SA Sastra, ... Cancer cell 25 (6), 735-747, 2014 | 1984 | 2014 |
| Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. ST Ju, DJ Panka, H Cui, R Ettinger, M el-Khatib, DH Sherr, BZ Stanger, ... Nature 373 (6513), 444-8, 1995 | 1874 | 1995 |
| Genetics and biology of pancreatic ductal adenocarcinoma AF Hezel, AC Kimmelman, BZ Stanger, N Bardeesy, RA DePinho Genes & development 20 (10), 1218-1249, 2006 | 1517 | 2006 |
| The death domain kinase RIP mediates the TNF-induced NF-κB signal MA Kelliher, S Grimm, Y Ishida, F Kuo, BZ Stanger, P Leder Immunity 8 (3), 297-303, 1998 | 1361 | 1998 |
| Guidelines and definitions for research on epithelial–mesenchymal transition J Yang, P Antin, G Berx, C Blanpain, T Brabletz, M Bronner, K Campbell, ... Nature reviews Molecular cell biology 21 (6), 341-352, 2020 | 1360 | 2020 |
| RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death BZ Stanger, P Leder, TH Lee, E Kim, B Seed Cell 81 (4), 513-523, 1995 | 1298 | 1995 |
| Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer LJ Bayne, GL Beatty, N Jhala, CE Clark, AD Rhim, BZ Stanger, ... Cancer cell 21 (6), 822-835, 2012 | 966 | 2012 |
| Notch signaling controls multiple steps of pancreatic differentiation LC Murtaugh, BZ Stanger, KM Kwan, DA Melton Proceedings of the National Academy of Sciences 100 (25), 14920-14925, 2003 | 882 | 2003 |
| Hippo pathway activity influences liver cell fate D Yimlamai, C Christodoulou, GG Galli, K Yanger, B Pepe-Mooney, ... Cell 157 (6), 1324-1338, 2014 | 818 | 2014 |
| Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020 | 801 | 2020 |
| EMT subtype influences epithelial plasticity and mode of cell migration NM Aiello, R Maddipati, RJ Norgard, D Balli, J Li, S Yuan, T Yamazoe, ... Developmental cell 45 (6), 681-695. e4, 2018 | 586 | 2018 |
| Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy J Li, KT Byrne, F Yan, T Yamazoe, Z Chen, T Baslan, LP Richman, JH Lin, ... Immunity 49 (1), 178-193. e7, 2018 | 560 | 2018 |
| Notch signaling controls liver development by regulating biliary differentiation Y Zong, A Panikkar, J Xu, A Antoniou, P Raynaud, F Lemaigre, ... Oxford University Press for The Company of Biologists Limited 136 (10), 1727 …, 2009 | 537 | 2009 |
| Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation JV Lee, A Carrer, S Shah, NW Snyder, S Wei, S Venneti, AJ Worth, ... Cell metabolism 20 (2), 306-319, 2014 | 536 | 2014 |
| Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. TL Rothstein, JK Wang, DJ Panka, LC Foote, Z Wang, B Stanger, H Cui H, ... Nature 374 (6518), 163-165, 1995 | 536 | 1995 |
| IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice RI Tepper, DA Levinson, BZ Stanger, J Campos-Torres, AK Abbas, ... Cell 62 (3), 457-467, 1990 | 525 | 1990 |
| Robust cellular reprogramming occurs spontaneously during liver regeneration K Yanger, Y Zong, LR Maggs, SN Shapira, R Maddipati, NM Aiello, ... Genes & development 27 (7), 719-724, 2013 | 516 | 2013 |
| Induction of T-cell immunity overcomes complete resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic carcinoma R Winograd, KT Byrne, RA Evans, PM Odorizzi, ARL Meyer, DL Bajor, ... Cancer immunology research 3 (4), 399-411, 2015 | 456 | 2015 |
